OneThree Biotech, the AI-powered drug discovery platform, has raised $2.8M in funding according to a recent SEC filing. The filing indicates that the total offering is for $3.8M, that there were five investors in this close, and this round includes the conversion of a previous SAFE Note in the amount of $302K. Brad Svrluga of Primary Venture Partners is listed as a Director. OneThree Biotech was founded by Neel S. Madhukar and Olivier Elemento in 2017 out of Weill Cornell.
Nominations are now open for AlleyWatch’s 2020 NYC Tech Influencers feature.
Know someone amazing who belongs on this list? Nominate them today here. Nominations open until 2/4. Looking to drive targeted response from the NYC Tech community at scale, learn more about partnering with AlleyWatch on this initiative here.